Largest biotech by net assets

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Gilead Sciences leads the 24 biotech ranked by net assets, at HK$178.1B, ahead of BioNTech (HK$167.3B) and Biogen (HK$143.2B). Figures as of 18 Nov 2026, 15:34 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
Gilead SciencesHK$178.1B
Median
HK$15.8B
Combined market value
HK$6.62T
Countries
5

Market values as of .

Largest biotech by net assets
#CompanyNet assets ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Gilead SciencesGILD · Health CareHK$178.1BHK$1.64THK$1,326.10 0.73% down 33% up United States
2BioNTechBNTX · Health CareHK$167.3BHK$164.1BHK$661.78 0.60% down 16% down Germany
3BiogenBIIB · Health CareHK$143.2BHK$289.3BHK$1,956.95 0.54% down 49% up United States
4AmgenAMGN · Health CareHK$67.9BHK$1.91THK$3,526.33 1.85% down 34% up United States
5ModernaMRNA · Health CareHK$67.9BHK$646.2BHK$1,597.03 1.57% down 755% up United States
6argenxARGX · Health CareHK$57.5BHK$470.7BHK$7,484.72 0.68% up 4% up Belgium
7QiagenQGEN · Health CareHK$29.6BHK$80.4BHK$389.19 0.29% down 12% up Netherlands
8Neurocrine BiosciencesNBIX · Health CareHK$25.5BHK$129.2BHK$1,276.67 1.93% down 20% up United States
9VaxcytePCVX · Health CareHK$21.1BHK$72.5BHK$457.95 1.73% down 22% up United States
10ExelixisEXEL · Health CareHK$17BHK$132BHK$540.88 0.64% up 63% up United States
11Bio-TechneTECH · Health CareHK$16.5BHK$89.6BHK$570.46 0.11% up 26% up United States
12RepligenRGEN · Health CareHK$16.5BHK$85.8BHK$1,341.69 5.44% up 5% up United States
13CRISPR TherapeuticsCRSP · Health CareHK$15.1BHK$31.7BHK$326.46 3.64% up 21% down Switzerland
14Revolution MedicinesRVMD · Health CareHK$12.8BHK$272BHK$1,257.67 1.47% down 131% up United States
15Kymera TherapeuticsKYMR · Health CareHK$12.4BHK$82BHK$960.47 0.74% up 87% up United States
16Krystal BiotechKRYS · Health CareHK$9.6BHK$71.8BHK$2,424.11 3.49% up 46% up United States
17ImmunovantIMVT · Health CareHK$6.7BHK$55BHK$265.66 1.96% up 43% up United States
18CG OncologyCGON · Health CareHK$5.9BHK$56.2BHK$629.46 1.63% up 85% up United States
19Twist BioscienceTWST · Health CareHK$3.7BHK$60.9BHK$893.82 1.72% up 340% up United States
20Scholar Rock HoldingSRRK · Health CareHK$1.9BHK$46BHK$376.99 6.59% up 14% up United States
21Adaptive BiotechnologiesADPT · Health CareHK$1.7BHK$36.3BHK$224.39 0.39% up 88% up United States
22Kodiak SciencesKOD · Health CareHK$1.2BHK$50.7BHK$775.35 2.09% up 396% up United States
23Halozyme TherapeuticsHALO · Health CareHK$383MHK$86.7BHK$760.13 0.95% up 37% up United States
24ImmunityBioIBRX · Health Care-HK$3.9BHK$55.6BHK$52.25 6.39% up 193% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 7.8457 HKD).

Questions and answers

Which biotech rank first by net assets?

Gilead Sciences (HK$178.1B), BioNTech (HK$167.3B) and Biogen (HK$143.2B) are the top three of the 24 biotech ranked by net assets as of 18 Nov 2026, 15:34 UTC.

How many biotech are in this ranking?

24 are ranked by net assets.

What are these biotech worth together?

The 24 biotech ranked by net assets have a combined market value of HK$6.62T as of 18 Nov 2026, 15:34 UTC.

What does ranking by net assets measure?

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Cite this page

Funkfolio, “Largest biotech by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=net-assets

Underlying data: Yahoo Finance; SEC EDGAR.